Varokibart Biosimilar - Research Grade

Human

IL5

5mg/ml

IgG4 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P05113

Blue ice

Interleukin-5 (IL5) is the dominant regulator of eosinophil biology and a long-standing target in eosinophilic and allergic disease research. This anti-human IL5 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of varokibart, provided strictly for research use only. Built to in vivo manufacturing standards with low endotoxin, it is produced in scalable milligram (mg) to gram (g) quantities suited to heavy-usage and high-throughput laboratories. It functions as a reliable neutralizing control and active reagent across cytokine assays, in vitro screening, and in vivo eosinophilic inflammation and asthma models.

Detects human IL5

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks